These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Synthesis of oligoarginine-oligonucleotide conjugates and oligoarginine-bridged oligonucleotide pairs. Wei Z; Tung CH; Zhu T; Stein S Bioconjug Chem; 1994; 5(5):468-74. PubMed ID: 7849079 [TBL] [Abstract][Full Text] [Related]
24. Preparation and evaluation of tumor-targeting peptide-oligonucleotide conjugates. Mier W; Eritja R; Mohammed A; Haberkorn U; Eisenhut M Bioconjug Chem; 2000; 11(6):855-60. PubMed ID: 11087334 [TBL] [Abstract][Full Text] [Related]
25. 3'-methylphosphonate-modified oligo-2'-O-methylribonucleotides and their Tat peptide conjugates: uptake and stability in mouse fibroblasts in culture. Prater CE; Miller PS Bioconjug Chem; 2004; 15(3):498-507. PubMed ID: 15149177 [TBL] [Abstract][Full Text] [Related]
26. [Peptide-oligonucleotide conjugates as a new generation of antisense elements]. Stetsenko DA; Arzumanov AA; Korshun VA; Gait MJ Mol Biol (Mosk); 2000; 34(6):998-1006. PubMed ID: 11186016 [No Abstract] [Full Text] [Related]
27. Fragment-based solid-phase assembly of oligonucleotide conjugates with peptide and polyethylene glycol ligands. Dirin M; Urban E; Noe CR; Winkler J Eur J Med Chem; 2016 Oct; 121():132-142. PubMed ID: 27236069 [TBL] [Abstract][Full Text] [Related]
28. Antisense inhibition of human telomerase by phosphorothioate oligonucleotide-peptide conjugates. Diala I; Murao S; Fujii M Nucleic Acids Symp Ser (Oxf); 2008; (52):679-80. PubMed ID: 18776562 [TBL] [Abstract][Full Text] [Related]
29. Synthesis of antisense oligonucleotide-peptide conjugate targeting to GLUT-1 in HepG-2 and MCF-7 Cells. Chen CP; Li XX; Zhang LR; Min JM; Chan JY; Fung KP; Wang SQ; Zhang LH Bioconjug Chem; 2002; 13(3):525-9. PubMed ID: 12009942 [TBL] [Abstract][Full Text] [Related]
30. A concise method for the preparation of peptide and arginine-rich peptide-conjugated antisense oligonucleotide. Chen CP; Zhang LR; Peng YF; Wang XB; Wang SQ; Zhang LH Bioconjug Chem; 2003; 14(3):532-8. PubMed ID: 12757376 [TBL] [Abstract][Full Text] [Related]
31. Synthesis of oligonucleotide-peptide conjugates for biomedical and technological applications. Aviñó A; Grijalvo S; Pérez-Rentero S; Garibotti A; Terrazas M; Eritja R Methods Mol Biol; 2011; 751():223-38. PubMed ID: 21674334 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death. Callebaut C; Jacotot E; Guichard G; Krust B; Rey-Cuille M; Cointe D; Benkirane N; Blanco J; Muller S; Briand J; Hovanessian AG Virology; 1996 Apr; 218(1):181-92. PubMed ID: 8615021 [TBL] [Abstract][Full Text] [Related]
33. 4-(2-aminooxyethoxy)-2-(ethylureido)quinoline-oligonucleotide conjugates: synthesis, binding interactions, and derivatization with peptides. Hamma T; Miller PS Bioconjug Chem; 2003; 14(2):320-30. PubMed ID: 12643742 [TBL] [Abstract][Full Text] [Related]
34. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions. Astriab-Fisher A; Sergueev D; Fisher M; Shaw BR; Juliano RL Pharm Res; 2002 Jun; 19(6):744-54. PubMed ID: 12134943 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups. Svinarchuk FP; Konevetz DA; Pliasunova OA; Pokrovsky AG; Vlassov VV Biochimie; 1993; 75(1-2):49-54. PubMed ID: 8504177 [TBL] [Abstract][Full Text] [Related]